Skip to content

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

A Multicentre, Observational Study to Understand the Distribution of Obesity Classes and Obesity Related Comorbidities (ORCs) in People With Obesity Within a Real World Population in Czech Republic, Hungary and Poland

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05795166
Acronym
ExplorEUEast
Enrollment
1241
Registered
2023-04-03
Start date
2023-04-27
Completion date
2023-11-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The study is intended to understand the distribution of different obesity classes and obesity related diseases (diseases that present along with obesity) in patients with body mass index (BMI) ≥ 30 kg/m\^2. Participants will be asked to give information about their health. They will continue their normal way of life and will not get any medication or additional medical test other than those prescribed to you by their doctor. Participation in the study will last for about 1 day.

Interventions

OTHERNo treatment given

No treatment given

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. Signed informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, age greater than or equal to 18 years at the time of inclusion/enrolment in the study. 3. BMI greater than or equal to 30 Kg/m\^2 as measured at the inclusion in the study

Exclusion criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study. 2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation as judged by physician.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients with at least one obesity related comorbidity of interest for obesity classes I, II and III pooled across all countriesAt the time of enrolment (Day 1)% patients with obesity

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026